Navigation Links
Instrument Manager™

ProductsInstrument Manager™
Company Data Innovations
Item Instrument Manager™
Features 
  • Windows-based, MDI model, software product, using a Visual Basic front end and a Cach database
  • No proprietary hardware needed
  • Able to maintain up to 128 concurrent connections
  • Library of over 500 drivers, connecting hospital information systems, laboratory instruments, point of care analyzers, automation systems, and more.
Description Data Innovations' Instrument Manager (IM) is an instrument and LIS independent connectivity and data management system that enables laboratories to work more efficiently than ever. It can be used as a data management solution that stands between instrument or medical devices and the information system, filling those important gaps in functionality between the two, as a connectivity solution that eases the burden on your laboratory information system, as a stand-alone small information system, and more. The minimum system requirements for Instrument Manager software are a Pentium class PC with 133 MHz or greater processor, 64 MB RAM, CD ROM, SVGA monitor, parallel port, mouse, network and/or serial cards as necessary, and Windows 98/XP, or Windows NT v4.0 with service pack 6 or later or Windows 2000 with service pack 2 or later.
Info Data Innovations
Customer Service: (802) 658-2850

Related medicine products :

1. Microsurgical Instrument Tray
2. Instrument Tray
3. Mayo Instrument Stand
4. Mobile Instrument Stand
5. Ultramatic RX Master PHOROPTOR Refracting Instrument - Minus Cylinder Black
6. Ultramatic RX Master PHOROPTOR Refracting Instrument - Plus Cylinder Black
7. Micromat II Hemoglobin A1c Instrument
8. Micromax High Performance Instrument System
9. Micromax Plus High Performance Instrument System
10. Emax High Performance Instrument System
11. Fahlbusch Hypophysectomie Instrument, Spoon
For the quantitative in vitro determination of Total Protein in serum and plasma...
The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of Rheumatoid Factor in serum....
For the quantitative in vitro determination of Carbon Dioxide in serum and plasma....
Medicine Products:
(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: